{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:27:29Z","timestamp":1788262049360,"version":"build-2803163510"},"reference-count":50,"publisher":"BMJ","issue":"2","funder":[{"name":"Guangzhou clinical high-tech project","award":["2023C-GX04"],"award-info":[{"award-number":["2023C-GX04"]}]},{"name":"Innovation Team of respiratory diseases and regenerative medicine","award":["ZNSA-2020013"],"award-info":[{"award-number":["ZNSA-2020013"]}]},{"name":"Zhongnanshan medical foundation of Guangdong Province","award":["ZNSA-2020013"],"award-info":[{"award-number":["ZNSA-2020013"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pulmonary alveolar proteinosis (PAP) is a rare interstitial lung disease characterised by the accumulation of lipoprotein material in the alveoli. Although dyslipidaemia is a prominet feature, the causal effect of lipid traits on PAP remains unclear. This study aimed to explore the role of lipid traits in PAP and evaluate the potential of lipid-lowering drug targets in PAP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Clinical outcomes, lipid profiles and lung function tests were analysed in a clinical cohort of diagnosed PAP patients and propensity score-matched healthy controls. Genome-wide association study data on PAP, lipid metabolism, blood cells and variants of genes encoding potential lipid-lowering drug targets were obtained for Mendelian randomisation (MR) and mediation analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Findings<\/jats:title><jats:p>Observational results showed that higher levels of total cholesterol (TC), triglycerides and low-density lipoprotein (LDL) were associated with increased risks of PAP. Higher levels of TC and LDL were also associated with worse PAP severity. In MR analysis, elevated LDL was associated with an increased risk of PAP (OR: 4.32, 95% CI: 1.63 to 11.61, p=0.018). Elevated monocytes were associated with a lower risk of PAP (OR 0.34, 95%\u2009CI: 0.18 to 0.66, p=0.002) and mediated the risk impact of LDL on PAP. Genetic mimicry of PCSK9 inhibition was associated with a reduced risk of PAP (OR 0.03, p=0.007).<\/jats:p><\/jats:sec><jats:sec><jats:title>Interpretation<\/jats:title><jats:p>Our results support the crucial role of lipid and metabolism-related traits in PAP risk, emphasising the monocyte-mediated, causal effect of elevated LDL in PAP genetics. PCSK9 mediates the development of PAP by raising LDL. These finding provide evidence for lipid-related mechanisms and promising lipid-lowering drug target for PAP.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thorax-2023-220789","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T18:20:22Z","timestamp":1702750822000},"page":"135-143","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Causal role of lipid metabolism in pulmonary alveolar proteinosis: an observational and mendelian randomisation study"],"prefix":"10.1136","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0984-9505","authenticated-orcid":false,"given":"Junfeng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zikai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuojia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengjia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangcheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,12,16]]},"reference":[{"key":"2024011804050894000_79.2.135.1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S2213-2600(18)30043-2","article-title":"Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach","volume":"6","author":"Kumar","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024011804050894000_79.2.135.2","doi-asserted-by":"crossref","unstructured":"McCarthy C , Avetisyan R , Carey BC , et al . Prevalence and healthcare burden of pulmonary alveolar proteinosis. Orphanet J Rare Dis 2018;13:129. doi:10.1186\/s13023-018-0846-y","DOI":"10.1186\/s13023-018-0846-y"},{"key":"2024011804050894000_79.2.135.3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-019-0066-3","article-title":"Pulmonary alveolar proteinosis","volume":"5","author":"Trapnell","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2024011804050894000_79.2.135.4","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200708-1271OC"},{"key":"2024011804050894000_79.2.135.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2009.01539.x"},{"key":"2024011804050894000_79.2.135.6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ccm.2016.04.006","article-title":"Pulmonary alveolar proteinosis syndrome","volume":"37","author":"Suzuki","year":"2016","journal-title":"Clin Chest Med"},{"key":"2024011804050894000_79.2.135.7","doi-asserted-by":"crossref","unstructured":"Tian X , Luo J , Xu K-F , et al . Impaired lipid metabolism in idiopathic pulmonary alveolar proteinosis. Lipids Health Dis 2011;10:54. doi:10.1186\/1476-511X-10-54","DOI":"10.1186\/1476-511X-10-54"},{"key":"2024011804050894000_79.2.135.8","doi-asserted-by":"crossref","unstructured":"Huang X , Cao M , Xiao Y . Alveolar macrophages in pulmonary alveolar proteinosis: origin, function, and therapeutic strategies. Front Immunol 2023;14:1195988. doi:10.3389\/fimmu.2023.1195988","DOI":"10.3389\/fimmu.2023.1195988"},{"key":"2024011804050894000_79.2.135.9","doi-asserted-by":"crossref","unstructured":"McCarthy C , Lee E , Bridges JP , et al . Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis. Nat Commun 2018;9:3127. doi:10.1038\/s41467-018-05491-z","DOI":"10.1038\/s41467-018-05491-z"},{"key":"2024011804050894000_79.2.135.10","doi-asserted-by":"crossref","unstructured":"Sallese A , Suzuki T , McCarthy C , et al . Targeting cholesterol homeostasis in lung diseases. Sci Rep 2017;7:10211. doi:10.1038\/s41598-017-10879-w","DOI":"10.1038\/s41598-017-10879-w"},{"key":"2024011804050894000_79.2.135.11","doi-asserted-by":"crossref","unstructured":"Fang CS , Wang YC , Zhang TH , et al . Clinical significance of serum lipids in idiopathic pulmonary alveolar proteinosis. Lipids Health Dis 2012;11:12. doi:10.1186\/1476-511X-11-12","DOI":"10.1186\/1476-511X-11-12"},{"key":"2024011804050894000_79.2.135.12","doi-asserted-by":"crossref","unstructured":"Yan X , Gao Y , Zhao Q , et al . Correlation of lipid ratios with the severity of pulmonary alveolar proteinosis: a cross-sectional study. Front Nutr 2021;8:610765. doi:10.3389\/fnut.2021.610765","DOI":"10.3389\/fnut.2021.610765"},{"key":"2024011804050894000_79.2.135.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.07.113"},{"key":"2024011804050894000_79.2.135.14","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx207"},{"key":"2024011804050894000_79.2.135.15","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25642"},{"key":"2024011804050894000_79.2.135.16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.0150"},{"key":"2024011804050894000_79.2.135.17","doi-asserted-by":"crossref","unstructured":"Xu F , Lu X , Cheng R , et al . The influence of exposure to Toxoplasma Gondii on host lipid metabolism. BMC Infect Dis 2020;20:415. doi:10.1186\/s12879-020-05138-9","DOI":"10.1186\/s12879-020-05138-9"},{"key":"2024011804050894000_79.2.135.18","doi-asserted-by":"crossref","unstructured":"Sakaue S , Yamaguchi E , Inoue Y , et al . Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis. Nat Commun 2021;12:1032. doi:10.1038\/s41467-021-21011-y","DOI":"10.1038\/s41467-021-21011-y"},{"key":"2024011804050894000_79.2.135.19","doi-asserted-by":"crossref","unstructured":"Liu Y , Basty N , Whitcher B , et al . Genetic architecture of 11 organ traits derived from abdominal MRI using deep learning. Elife 2021;10:e65554. doi:10.7554\/eLife.65554","DOI":"10.7554\/eLife.65554"},{"key":"2024011804050894000_79.2.135.20","doi-asserted-by":"publisher","DOI":"10.1038\/S41586-021-04103-Z"},{"key":"2024011804050894000_79.2.135.21","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddy271"},{"key":"2024011804050894000_79.2.135.22","doi-asserted-by":"crossref","unstructured":"Richardson TG , Sanderson E , Palmer TM , et al . Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable mendelian randomisation analysis. PLoS Med 2020;17:e1003062. doi:10.1371\/journal.pmed.1003062","DOI":"10.1371\/journal.pmed.1003062"},{"key":"2024011804050894000_79.2.135.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.08.008"},{"key":"2024011804050894000_79.2.135.24","doi-asserted-by":"crossref","unstructured":"Huang W , Xiao J , Ji J , et al . Association of lipid-lowering drugs with COVID-19 outcomes from a mendelian randomization study. Elife 2021;10:e73873. doi:10.7554\/eLife.73873","DOI":"10.7554\/eLife.73873"},{"key":"2024011804050894000_79.2.135.25","doi-asserted-by":"crossref","first-page":"104543","DOI":"10.1016\/j.ebiom.2023.104543","article-title":"Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease","volume":"90","author":"Li","year":"2023","journal-title":"eBioMedicine"},{"key":"2024011804050894000_79.2.135.26","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080"},{"key":"2024011804050894000_79.2.135.27","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21965"},{"key":"2024011804050894000_79.2.135.28","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx102"},{"key":"2024011804050894000_79.2.135.29","doi-asserted-by":"crossref","unstructured":"Sanderson E . Multivariable mendelian randomization and mediation. Cold Spring Harb Perspect Med 2021;11:a038984. doi:10.1101\/cshperspect.a038984","DOI":"10.1101\/cshperspect.a038984"},{"key":"2024011804050894000_79.2.135.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2004.04.002"},{"key":"2024011804050894000_79.2.135.31","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.3.252"},{"key":"2024011804050894000_79.2.135.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2008.03.021"},{"key":"2024011804050894000_79.2.135.33","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.physiol.64.090601.113847"},{"key":"2024011804050894000_79.2.135.34","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20162152"},{"key":"2024011804050894000_79.2.135.35","doi-asserted-by":"crossref","first-page":"292","DOI":"10.14348\/molcells.2021.0058","article-title":"Development and functions of alveolar macrophages","volume":"44","author":"Woo","year":"2021","journal-title":"Mol Cells"},{"key":"2024011804050894000_79.2.135.36","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3005"},{"key":"2024011804050894000_79.2.135.37","unstructured":"Linton MF , Yancey PG , Davies SS , et al . The role of lipids and lipoproteins in Atherosclerosis. In: Feingold KR , Anawalt B , Blackman MR , et al ., eds. Endotext. South Dartmouth (MA): MDText.com, Inc. Copyright \u00a9 2000-2023, 2000."},{"key":"2024011804050894000_79.2.135.38","doi-asserted-by":"publisher","DOI":"10.5551\/jat.55400"},{"key":"2024011804050894000_79.2.135.39","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0022-2275(20)32515-3","article-title":"Lysosomal sequestration of free and esterified cholesterol from oxidized low density lipoprotein in macrophages of different species","volume":"39","author":"Yancey","year":"1998","journal-title":"J Lipid Res"},{"key":"2024011804050894000_79.2.135.40","doi-asserted-by":"publisher","DOI":"10.1038\/nature13807"},{"key":"2024011804050894000_79.2.135.41","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000140762.04598.F9"},{"key":"2024011804050894000_79.2.135.42","doi-asserted-by":"crossref","unstructured":"Shi S , Gui X , Ding J , et al . Assessment of statin treatment for pulmonary alveolar proteinosis without hypercholesterolemia: a 12-month prospective, longitudinal, and observational study. Biomed Res Int 2022;2022:1589660. doi:10.1155\/2022\/1589660","DOI":"10.1155\/2022\/1589660"},{"key":"2024011804050894000_79.2.135.43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.001592"},{"key":"2024011804050894000_79.2.135.44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jamacardio.2018.4178","article-title":"Interindividual variation in low-density lipoprotein cholesterol level reduction with evolocumab: an analysis of FOURIER trial data","volume":"4","author":"Qamar","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2024011804050894000_79.2.135.45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrcardio.2017.75","article-title":"Dyslipidaemia: PCSK9 inhibitors and foamy monocytes in familial hypercholesterolaemia","volume":"14","author":"Wu","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2024011804050894000_79.2.135.46","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/cvr\/cvz313","article-title":"PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1","volume":"116","author":"Ding","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2024011804050894000_79.2.135.47","doi-asserted-by":"crossref","first-page":"582865","DOI":"10.3389\/fcvm.2020.582865","article-title":"PCSK9 gene E670G polymorphism and coronary artery disease: an updated meta-analysis of 5,484 subjects","volume":"7","author":"Li","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"2024011804050894000_79.2.135.48","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200502078"},{"key":"2024011804050894000_79.2.135.49","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401444"},{"key":"2024011804050894000_79.2.135.50","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx002"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2023-220789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T12:07:24Z","timestamp":1705579644000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2023-220789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,16]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,18]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/thorax-2023-220789"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2023-220789","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,16]]}}}